MoneyWorks4Me

Dr. Reddy’s Laboratories informs about disclosure on related party transactions

17 Aug 2022 Evaluate

Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Reddy’s Laboratories has informed that it enclosed the applicable disclosure on related party transactions for the half year ended March 31, 2022, in the requisite format.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..